Emami Limited (EMAMILTD) - Net Assets
Based on the latest financial reports, Emami Limited (EMAMILTD) has net assets worth Rs29.22 Billion INR (≈ $316.05 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs38.36 Billion ≈ $414.90 Million USD) and total liabilities (Rs9.14 Billion ≈ $98.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Emami Limited to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs29.22 Billion |
| % of Total Assets | 76.18% |
| Annual Growth Rate | 11.17% |
| 5-Year Change | 40.89% |
| 10-Year Change | 66.42% |
| Growth Volatility | 24.87 |
Emami Limited - Net Assets Trend (2005–2026)
This chart illustrates how Emami Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see EMAMILTD market cap.
Annual Net Assets for Emami Limited (2005–2026)
The table below shows the annual net assets of Emami Limited from 2005 to 2026. Also explore how fast is Emami Limited growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs29.22 Billion ≈ $316.05 Million |
+8.51% |
| 2025-03-31 | Rs26.93 Billion ≈ $291.28 Million |
+9.59% |
| 2024-03-31 | Rs24.58 Billion ≈ $265.79 Million |
+6.27% |
| 2023-03-31 | Rs23.13 Billion ≈ $250.12 Million |
+11.50% |
| 2022-03-31 | Rs20.74 Billion ≈ $224.33 Million |
+17.74% |
| 2021-03-31 | Rs17.62 Billion ≈ $190.53 Million |
-3.35% |
| 2020-03-31 | Rs18.23 Billion ≈ $197.14 Million |
-12.19% |
| 2019-03-31 | Rs20.76 Billion ≈ $224.50 Million |
+3.06% |
| 2018-03-31 | Rs20.14 Billion ≈ $217.83 Million |
+14.70% |
| 2017-03-31 | Rs17.56 Billion ≈ $189.92 Million |
+24.79% |
| 2016-03-31 | Rs14.07 Billion ≈ $152.19 Million |
+13.93% |
| 2015-03-31 | Rs12.35 Billion ≈ $133.58 Million |
+32.51% |
| 2014-03-31 | Rs9.32 Billion ≈ $100.81 Million |
+19.92% |
| 2013-03-31 | Rs7.77 Billion ≈ $84.06 Million |
+9.98% |
| 2012-03-31 | Rs7.07 Billion ≈ $76.43 Million |
+2.44% |
| 2011-03-31 | Rs6.90 Billion ≈ $74.61 Million |
+10.31% |
| 2010-03-31 | Rs6.25 Billion ≈ $67.64 Million |
+107.61% |
| 2009-03-31 | Rs3.01 Billion ≈ $32.58 Million |
+5.00% |
| 2008-03-31 | Rs2.87 Billion ≈ $31.03 Million |
+25.10% |
| 2007-03-31 | Rs2.29 Billion ≈ $24.80 Million |
-31.50% |
| 2006-03-31 | Rs3.35 Billion ≈ $36.21 Million |
+5.78% |
| 2005-03-31 | Rs3.17 Billion ≈ $34.23 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Emami Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2342015600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs23.42 Billion | 80.10% |
| Common Stock | Rs436.50 Million | 1.49% |
| Other Comprehensive Income | Rs5.38 Billion | 18.41% |
| Other Components | Rs44.00K | 0.00% |
| Total Equity | Rs29.24 Billion | 100.00% |
Emami Limited Competitors by Market Cap
The table below lists competitors of Emami Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
IQM Quantum Computers Oyj American Depositary Shares
NASDAQ:IQMX
|
$1.76 Billion |
|
Melco Resorts & Entertainment Ltd
NASDAQ:MLCO
|
$1.76 Billion |
|
Cimpress plc
F:3UF
|
$1.77 Billion |
|
Surgery Partners Inc
NASDAQ:SGRY
|
$1.77 Billion |
|
Elang Mahkota Teknologi Tbk
JK:EMTK
|
$1.76 Billion |
|
Hawaiian Electric Industries Inc
NYSE:HE
|
$1.76 Billion |
|
Dynavax Technologies Corporation
NASDAQ:DVAX
|
$1.76 Billion |
|
Solar Applied Materials Technology
TWO:1785
|
$1.76 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Emami Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 26,947,900,000 to 29,239,800,000, a change of 2,291,900,000 (8.5%).
- Net income of 7,752,700,000 contributed positively to equity growth.
- Dividend payments of 5,238,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 182,713,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs7.75 Billion | +26.51% |
| Dividends Paid | Rs5.24 Billion | -17.91% |
| Other Comprehensive Income | Rs-182.71 Million | -0.62% |
| Other Changes | Rs-40.09 Million | -0.14% |
| Total Change | Rs- | 8.50% |
Book Value vs Market Value Analysis
This analysis compares Emami Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 39.88x to 5.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-03-31 | Rs9.37 | Rs373.70 | x |
| 2006-03-31 | Rs9.13 | Rs373.70 | x |
| 2007-03-31 | Rs6.15 | Rs373.70 | x |
| 2008-03-31 | Rs7.68 | Rs373.70 | x |
| 2009-03-31 | Rs7.90 | Rs373.70 | x |
| 2010-03-31 | Rs14.28 | Rs373.70 | x |
| 2011-03-31 | Rs15.20 | Rs373.70 | x |
| 2012-03-31 | Rs15.57 | Rs373.70 | x |
| 2013-03-31 | Rs17.12 | Rs373.70 | x |
| 2014-03-31 | Rs20.53 | Rs373.70 | x |
| 2015-03-31 | Rs27.11 | Rs373.70 | x |
| 2016-03-31 | Rs30.91 | Rs373.70 | x |
| 2017-03-31 | Rs38.66 | Rs373.70 | x |
| 2018-03-31 | Rs44.36 | Rs373.70 | x |
| 2019-03-31 | Rs45.73 | Rs373.70 | x |
| 2020-03-31 | Rs40.18 | Rs373.70 | x |
| 2021-03-31 | Rs39.66 | Rs373.70 | x |
| 2022-03-31 | Rs46.73 | Rs373.70 | x |
| 2023-03-31 | Rs52.21 | Rs373.70 | x |
| 2024-03-31 | Rs55.95 | Rs373.70 | x |
| 2025-03-31 | Rs61.75 | Rs373.70 | x |
| 2026-03-31 | Rs66.98 | Rs373.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Emami Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.51%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 20.51%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 1.31x
- Recent ROE (26.51%) is below the historical average (27.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 9.24% | 14.70% | 0.54x | 1.17x | Rs-23.92 Million |
| 2006 | 14.72% | 17.78% | 0.68x | 1.22x | Rs157.92 Million |
| 2007 | 28.87% | 13.65% | 1.46x | 1.45x | Rs432.70 Million |
| 2008 | 31.49% | 15.44% | 1.07x | 1.91x | Rs615.43 Million |
| 2009 | 30.49% | 12.79% | 0.77x | 3.10x | Rs617.34 Million |
| 2010 | 27.14% | 17.49% | 0.92x | 1.68x | Rs1.07 Billion |
| 2011 | 33.15% | 19.03% | 1.09x | 1.59x | Rs1.60 Billion |
| 2012 | 36.63% | 18.89% | 1.16x | 1.67x | Rs1.88 Billion |
| 2013 | 40.49% | 19.73% | 1.38x | 1.48x | Rs2.37 Billion |
| 2014 | 43.18% | 23.68% | 1.31x | 1.40x | Rs3.09 Billion |
| 2015 | 39.46% | 23.39% | 1.24x | 1.36x | Rs3.63 Billion |
| 2016 | 25.91% | 15.41% | 0.89x | 1.90x | Rs2.23 Billion |
| 2017 | 19.40% | 13.68% | 0.95x | 1.49x | Rs1.65 Billion |
| 2018 | 15.25% | 12.14% | 0.90x | 1.39x | Rs1.06 Billion |
| 2019 | 14.61% | 11.25% | 0.95x | 1.36x | Rs956.24 Million |
| 2020 | 16.61% | 11.41% | 0.99x | 1.47x | Rs1.21 Billion |
| 2021 | 25.80% | 15.79% | 1.14x | 1.43x | Rs2.78 Billion |
| 2022 | 40.40% | 26.32% | 1.04x | 1.47x | Rs6.31 Billion |
| 2023 | 27.77% | 18.78% | 1.10x | 1.35x | Rs4.09 Billion |
| 2024 | 29.57% | 20.22% | 1.09x | 1.34x | Rs4.79 Billion |
| 2025 | 29.93% | 21.17% | 1.08x | 1.31x | Rs5.37 Billion |
| 2026 | 26.51% | 20.51% | 0.99x | 1.31x | Rs4.83 Billion |
Industry Comparison
This section compares Emami Limited's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $62,287,328,252
- Average return on equity (ROE) among peers: 22.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Emami Limited (EMAMILTD) | Rs29.22 Billion | 9.24% | 0.31x | $1.76 Billion |
| Ambica Agarbathies & Aroma industries Limited (AMBICAAGAR) | $359.58 Million | 3.99% | 2.05x | $4.63 Million |
| Bajaj Consumer Care Limited (BAJAJCON) | $4.92 Billion | 42.86% | 0.23x | $711.66 Million |
| Colgate Palmolive (India) Limited (COLPAL) | $15.25 Billion | 44.17% | 0.68x | $5.35 Billion |
| Cupid Limited (CUPID) | $1.42 Billion | 12.15% | 0.22x | $4.14 Billion |
| Dabur India Limited (DABUR) | $21.36 Billion | 35.73% | 1.22x | $7.38 Billion |
| Hindustan Unilever Limited (HINDUNILVR) | $505.22 Billion | 20.03% | 0.45x | $49.25 Billion |
| Honasa Consumer Limited (HONASA) | $10.95 Billion | 10.21% | 0.49x | $1.61 Billion |
| Kaya Limited (KAYA) | $-1.39 Billion | 0.00% | 0.00x | $51.92 Million |
| Procter & Gamble Hygiene and Health Care Limited (PGHH) | $2.49 Billion | 37.00% | 0.93x | $2.64 Billion |
About Emami Limited
Emami Limited manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic cream, body lotion, prickly heat powder, petroleum jelly, soaps, aloe vera gel, and all-season cream under the BoroPlus brand; oil and cool talc products under the Navratna brand; and ayurvedic products for pain management, immunity, digestive health, and bone and jo… Read more